Table 3.
Parameters | Intra- vs. pre-treatment study, mean +/-SD (p-value) | Post- vs. intra-treatment study, mean +/− SD (p-value) |
---|---|---|
ET-Ktrans max | −0.001 +/− 0.06 (>.05) | 0.002 +/− 0.3 (>.05) |
AATH-Ktrans max | −0.02 +/− 0.06 (>.05) | −0.06 +/− 0.2 (> 0.05) |
ET-kep max | −0.1 +/− 0.5 (>.05) | 0.05 +/− 0.8 (>.05) |
AATH-kep max | 0.1 +/− 1.6 (>.05) | - 0.2 +/− 1.7 (>.05) |
ET-AUC max | − 5062 +/− 26,775 (>.05) | − 9783 +/− 29,591 (>.05) |
AATH-AUC max | − 3310 +/− 27,804 (>.05) | − 9606 +/− 25,440 (>.05) |
ET-vp max | - 0.01 +/− 0.3 (>.05) | − 0.04 +/− 0.3 (>.05) |
AATH-vp max | 0 | 0 |
ET-ve med | 0.009 +/− 0.2 (>.05) | −0.05 +/− 0.3 (>.05) |
AATH-ve med | 0.07 +/− 0.2 (>.05) | − 0.09 +/− 0.4 (> 0.05) |
TC-max | 6 +/− 62. (>.05) | −4 +/− 68 (>.05) |
E-max | 0.009 +/− 0.02 (>.05) | − 0.005 +/− 0.02 (>.05) |
F-max | −10 +/− 34 (.05) | 40 +/− 168 (>.05) |
Note: Ktrans (1/min), kep (1/min), AUC (mM), ve (ml/100 ml), vp (ml/100 ml), TC (min), F (ml/min/100 ml), E (%)